Guru Ownership Trend
Guru Analysis for Krystal Biotech, Inc. (KRYS)
Krystal Biotech, Inc. (KRYS), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 6 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $38.67 M.
Top institutional holders include Ray Dalio and Ken Fisher.
Institutional sentiment is currently Bullish. This is evidenced by a $20.6 M net inflow during the quarter.
Recent activity highlights Paul Tudor Jones who increased their stake by 952.8%. Conversely, Cliff Asness reduced exposure by 0.3%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Krystal Biotech, Inc. (KRYS)
Major holders include Ray Dalio ($11.98 M), Ken Fisher ($7.18 M), Paul Tudor Jones ($3.74 M). According to the latest reported data, 6 tracked investment managers collectively hold approximately 113,664 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $20.6 M, with 5 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited KRYS. The total reported sell value was $11,107.76.
Yes, 0 managers opened new positions in KRYS, and 5 increased their existing holdings. The total reported buy value was $20.61 M.